Home
Storia in 2 fonti
Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill
The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.
- ·
cnbc.com
Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill
The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.
- ·
forbes.com
Pfizer To Pay $150 Million Upfront To Fosun Pharma In New China Move
Partnership follows tie-up with China's 3SBio earlier this year